| Issue |
Med Sci (Paris)
Volume 32, Number 12, Décembre 2016
|
|
|---|---|---|
| Page(s) | 1056 - 1059 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20163212004 | |
| Published online | 03 January 2017 | |
La molécule antivirale arbidol inhibe des virus pathogènes de prévalence mondiale
The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses
1
Université de Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre de Recherche en Cancérologie de Lyon, 151, cours Albert Thomas, 69003 Lyon, France
2
Departments of Laboratory Medicine and Global Health, University of Washington, Seattle, Washington, États-Unis
*
eve-isabelle.pecheur@inserm.fr
Cet article ne possède pas de résumé.
© 2016 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
